Early ovarian cancer detection through Pap test DNA analysis
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests whether DNA found in routine Pap smears can help detect ovarian cancer early in people at high genetic risk. Participants have inherited gene mutations that increase ovarian cancer risk and are considering preventive surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a known inherited gene mutation (like BRCA1 or BRCA2) that increases ovarian cancer risk
- You are considering or planning risk-reducing surgery to remove your ovaries and fallopian tubes
- You are able to understand the study and willing to sign a consent form
- You are willing and able to follow all study procedures and requirements
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic changes in ovarian cancer to find possible targeted treatments. It may help you if you have certain types of ovarian cancer and are seeking more personalized care.
This study looks at how medical images relate to genetic patterns in high-grade serous ovarian cancer. It may help find better ways to diagnose and treat this specific type of ovarian cancer.
This study looks at whether a score based on your genes can predict the risk of epithelial ovarian cancer. It compares women newly diagnosed with this cancer to women who have never had it.
This study follows women who carry gene mutations that increase ovarian cancer risk to understand how preventive surgery affects their health, quality of life, and peace of mind. Researchers will track your outcomes over 3 years to help inform future treatment decisions for others at similar risk.
This study looks at family members of people with ovarian cancer to build a better tool for predicting their risk. If you have a BRCA1 or BRCA2 gene mutation, you may be able to join.
This study looks at whether certain genetic mutations can help predict the risk of getting ovarian cancer. It aims to better understand how these inherited changes lead to the disease, which could help with early detection and prevention.
Hear when a new Germline Mutations trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.